Demant A/S (DEMANT.CO)
365.80 DKK -0.97%
Demant A/S fell 0.97% in the latest session, at 365.80 DKK. By market cap it is number 4 of the 9 health care stocks on the C25 heatmap. Its trailing P/E of 31.9 is below the median of those peers (36.3). The price is 2.5% below its 52-week high.
Key numbers
- Price
- 365.80 DKK
- Day change
- -0.97% (-3.60)
- Market cap
- 77.1B DKK
- P/E (trailing)
- 31.9
- P/E (forward)
- 21.2
- Dividend yield
- —
- 50-day average
- 321.13
- 200-day average
- 254.04
- 52-week range
- 175.00 – 375.00
Data as of 3 Nov 2026, 16:59 CET. Market data may be delayed.
Demant A/S over the past year
From daily closing prices. The highest close in the period was 369.40 DKK on 2 Nov 2026, the lowest 176.20 DKK on 13 Feb 2026.
| 1 month | 3 months | 6 months | Year to date | 1 year |
|---|---|---|---|---|
| +16.50% | +28.53% | +78.61% | +69.98% | +67.03% |
| Month | Close (DKK) | Change |
|---|---|---|
| November 2026 | 365.80 | +0.11% |
| October 2026 | 365.40 | +17.87% |
| September 2026 | 310.00 | +7.42% |
| August 2026 | 288.60 | +2.70% |
| July 2026 | 281.00 | +4.77% |
| June 2026 | 268.20 | +7.19% |
| May 2026 | 250.20 | +23.86% |
| April 2026 | 202.00 | +4.18% |
| March 2026 | 193.90 | -1.47% |
| February 2026 | 196.80 | -10.71% |
| January 2026 | 220.40 | +2.42% |
| December 2025 | 215.20 | -1.82% |
Health care peers
Demant A/S is on the C25 heatmap (Health care). How it compares with the other health care stocks there, by market cap:
| Company | Today | Market cap | P/E |
|---|---|---|---|
| Novo Nordisk A/S NOVO-B.CO | -0.02% | 1.19T DKK | 10.3 |
| Genmab A/S GMAB.CO | +0.57% | 229B DKK | 45.9 |
| Coloplast A/S COLO-B.CO | +2.97% | 112B DKK | 36.3 |
| Demant A/S DEMANT.CO | -0.97% | 77.1B DKK | 31.9 |
| ALK-Abelló A/S ALK-B.CO | +0.65% | 54.7B DKK | 40.5 |
| Ambu A/S AMBU-B.CO | +0.86% | 21.5B DKK | 42.9 |
| Bavarian Nordic A/S BAVA.CO | -2.71% | 18.2B DKK | 12.5 |
| GN Store Nord A/S GN.CO | +0.71% | 15.6B DKK | — |
| Zealand Pharma A/S ZEAL.CO | +1.17% | 15.5B DKK | 6.1 |
More on DEMANT
Open DEMANT.CO in zysk for the live chart, news, earnings and dividends, and ask the AI why it moved: it answers in a few lines with sources and a chart (how zysk's AI stock research works). zysk explains facts, news and risks; it is not investment advice.